Periganglionic Resiniferatoxin for the Treatment of Intractable Pain Due to Cancer-induced Bone Pain
Clinical trial NCT02522611 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT02522611
- Sponsor
- National Institute of Neurological Disorders and Stroke (NINDS)
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-27
- Primary completion
- 2026-12-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.